Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Eos Energy Enterprises Inc (EOSE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Eos Energy Enterprises Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.55 (market cap $4.59B), while Eos Energy Enterprises Inc trades at $2.8 (market cap $1.01B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 4.5× Eos Energy Enterprises Inc's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Eos Energy Enterprises Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Eos Energy Enterprises Inc for 16 Days on average.
| DFTX | EOSE | |
|---|---|---|
Market Cap | $4.59B | $1.01B |
Volume | 2,103,937 | 39,626,541 |
Sector | Health | Industrials |
52-Week High | $48.45 | $19.19 |
52-Week Low | $10.68 | $2.77 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $3.55B | $1.34B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eos Energy Enterprises (EOSE) trades at $3.10, down 4.91% today, amid a bearish technical signal. The company is in a high-growth phase, with revenue surging from $114 million in 2025 to $214 million in 2026, but it remains deeply unprofitable, with a net income margin of -246.76% in 2026. Recent positive developments include a major partnership with Google for a $350 million West Virginia project and an $87 million Department of Energy loan advance to expand manufacturing capacity.
The outlook is a high-risk, high-reward proposition. Significant revenue growth and strategic partnerships offer substantial upside potential, with a consensus price target of $7.10. However, persistent negative cash flow from operations, high debt-to-asset ratio of 91.87%, and intense competition in the energy storage sector pose severe risks to shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Eos Energy Enterprises Inc
Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Read more on EOSE →
